Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy | Zendy

Luke K. Kim | Zendy; Rajesh V. Swaminathan | Zendy; Patrick Looser | Zendy; Robert M. Minutello | Zendy; S. Chiu Wong | Zendy; Geoffrey Bergman | Zendy; Srihari S. Naidu | Zendy; Christopher L. Gade | Zendy; Konstantinos Charitakis | Zendy; Harsimran Singh | Zendy; Dmitriy N. Feldman | Zendy

Open Access

Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy

Author(s) -

Luke K. Kim,

Rajesh V. Swaminathan,

Patrick Looser,

Robert M. Minutello,

S. Chiu Wong,

Geoffrey Bergman,

Srihari S. Naidu,

Christopher L. Gade,

Konstantinos Charitakis,

Harsimran Singh,

Dmitriy N. Feldman

Publication year - 2016

Publication title -

jama cardiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.108

H-Index - 63

eISSN - 2380-6591

pISSN - 2380-6583

DOI - 10.1001/jamacardio.2016.0252

Subject(s) - medicine , alcohol septal ablation , incidence (geometry) , heart failure , hypertrophic cardiomyopathy , cardiology , adverse effect , obstructive cardiomyopathy , optics , physics

Previous data on septal myectomy (SM) and alcohol septal ablation (ASA) in obstructive hypertrophic cardiomyopathy have been limited to small, nonrandomized, single-center studies. Use of septal reduction therapy and the effect of institutional experience on procedural outcomes nationally are unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog